Preventing Central Catheter-Associated Bloodstream Infections

NCT ID: NCT04920877

Last Updated: 2021-06-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-06-04

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The research is an algorithm study focused on nursing care in order to prevent Central Catheter-Associated Bloodstream Infections in intensive care units. The algorithm prepared with infection control measures related to central catheter care will be applied with intensive care nurses and the effect of the algorithm on central catheter-related bloodstream infections will be examined. In practice, a 20-day preliminary assessment, a three-month intervention period, and a three-month post-intervention planning were made.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the light of literature review and guidelines, intensive care nurses will care for central catheters through an algorithm created with infection control measures.

Nurse-focused algorithm content to prevent central catheter-related bloodstream infections Hand hygiene practice Use of personal protective equipment according to infection control measures Evaluation of the catheter insertion site in terms of redness, swelling, tenderness, discharge, bleeding Use of \>0.5% chlorhexidine solution containing 70% alcohol for skin antisepsis at the catheter insertion site (if there is no chlorhexidine, povidone iodine + 70% alcohol solution is used) Changing the transparent, semi-permeable dressings every 5-7 days and gauze dressings every 48 hours for catheter dressing Catheter dressing with aseptic technique Use of sterile, preservative-free saline for flushing and locking in order to ensure the lumen of the catheter.

Aseptic conditions should be observed if the junction of the catheter and the infusion set (Hub) is to be touched.

Keeping the used triple taps closed Changing IV fluid sets and connection tools at appropriate times Daily assessment of CVC requirement The research will be carried out in the 1st, 2nd and 3rd Level Intensive Care Units of Bilecik Training and Research Hospital in Bilecik, Turkey. Infection rates will be compared in the study. In the study, the date of June 2021 will be taken as a preliminary assessment and training time for nurses. July-September 2021 will be the intervention period of the study, and October-December 2021 will be the post-intervention period.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Catheter Infection Catheter Infections Related

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Patients followed with a central catheter in the intensive care unit
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Central catheter-related bloodstream infection rates in intensive care units

Group Type EXPERIMENTAL

Infection Prevention

Intervention Type OTHER

Preventing central catheter-related bloodstream infections in intensive care units

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Infection Prevention

Preventing central catheter-related bloodstream infections in intensive care units

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A central venous catheter was inserted in the intensive care unit or before the intensive care unit admission, and being followed up in the intensive care unit with a central venous catheter.

Exclusion Criteria

* Patients whose central venous catheter was terminated during intensive care follow-up.
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Abant Izzet Baysal University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Aysun ACUN

Research Assistant

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AIBU-SBF-AA-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Central Venous Catheter-Related Infection
NCT00533988 COMPLETED PHASE4